Literature DB >> 19942714

Thyroid cancer and renal transplantation: a meta-analysis.

Dheeraj Karamchandani1, Ramiro Arias-Amaya, Nora Donaldson, Jackie Gilbert, Klaus-Martin Schulte.   

Abstract

Kidney transplantation and the associated immune suppression are associated with a significantly increased risk of developing cancer during long-term follow-up. Thyroid cancer has been recognised as a potential post-transplant risk but has not yet been subject of a focused review. We therefore performed a meta-analysis on data of 50,861 patients with a total follow-up of 198 595 patient-years and identified a 6.9-fold higher standardised incidence ratio (95% confidence interval 5.6-8.7, P<0.001) of thyroid cancer post renal transplantation as compared with a non-transplant group. All such cancers were of papillary type as far as histopathology was known. The mean time to discovery was 6.0 years post transplantation. This puts thyroid cancer into the group of high cancer risk following solid organ transplantation which already includes cervical cancer, non-melanoma skin cancer, oral and lip cancer and haematological malignancies. It is unclear what causes the increased cancer incidence. Inclusion of thyroid ultrasound in long-term post-transplant evaluation may help to ensure timely recognition of this condition.

Entities:  

Mesh:

Year:  2010        PMID: 19942714     DOI: 10.1677/ERC-09-0191

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  10 in total

1.  Effects of solid organ transplantation on the risk of developing thyroid cancer: a systematic review and meta-analysis.

Authors:  Liang Hu; Yijun Wu; Fangyu Ju; Yaohui Zhang; Weilin Wang
Journal:  Gland Surg       Date:  2022-04

2.  Risk of Thyroid Cancer Among Solid Organ Transplant Recipients.

Authors:  C M Kitahara; E L Yanik; P W Ladenson; B Y Hernandez; C F Lynch; K S Pawlish; E A Engels
Journal:  Am J Transplant       Date:  2017-05-30       Impact factor: 9.369

3.  Increased incidence of head and neck cancer in liver transplant recipients: a meta-analysis.

Authors:  Qian Liu; Lifeng Yan; Cheng Xu; Aihua Gu; Peng Zhao; Zhao-Yan Jiang
Journal:  BMC Cancer       Date:  2014-10-22       Impact factor: 4.430

4.  Thyroid Pathology in End-Stage Renal Disease Patients on Hemodialysis.

Authors:  Laura Cotoi; Florin Borcan; Ioan Sporea; Daniela Amzar; Oana Schiller; Adalbert Schiller; Cristina A Dehelean; Gheorghe Nicusor Pop; Andreea Borlea; Dana Stoian
Journal:  Diagnostics (Basel)       Date:  2020-04-23

5.  Thyroid disease and cancer in kidney transplantation: a single-center analysis.

Authors:  Massimiliano Veroux; Giuseppe Giuffrida; Salvatore Lo Bianco; Matteo Angelo Cannizzaro; Daniela Corona; Alessia Giaquinta; Chiara Palermo; Fausto Carbone; Anna Carbonaro; Maria Teresa Cannizzaro; Rossella Gioco; Pierfrancesco Veroux
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

6.  Lessons learned from conducting disease monitoring in low-dose exposure conditions as a counter-measure after a nuclear disaster.

Authors:  Akira Ohtsuru; Sanae Midorikawa
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724

7.  Analysis of clinicopathological features of papillary thyroid carcinoma in solid organ transplant recipients: a retrospective study.

Authors:  Liang Hu; Yijun Wu; Fangyu Ju; Yaohui Zhang; Weilin Wang
Journal:  Gland Surg       Date:  2022-08

8.  Risk of bladder cancer in renal transplant recipients: a meta-analysis.

Authors:  L Yan; P Chen; E-Z Chen; A Gu; Z-Y Jiang
Journal:  Br J Cancer       Date:  2014-02-04       Impact factor: 7.640

9.  Cancer risks in recipients of renal transplants: a meta-analysis of cohort studies.

Authors:  Yu Wang; Gong-Bin Lan; Feng-Hua Peng; Xu-Biao Xie
Journal:  Oncotarget       Date:  2017-12-16

10.  No significant association between immunosuppression in solid organ transplantation and prostate cancer risk: a meta-analysis of cohort studies.

Authors:  Ji-Ming Bao; Hai-Li Zhu; Guo-Sheng Yang; Peng-Liang Chen; Qiang Dang; Xing-Xing Chen; Kai-Qiang Tang; Yong-Tong Zhu; Xu-Wei Hong; Wan-Long Tan
Journal:  Transl Cancer Res       Date:  2019-06       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.